| Amyris is an industrial biotechnology company that is applies its technology platform to engineer, manufacture and sell products into the Health and Wellness, Clean Skincare, and Flavors and Fragrances markets. Co.'s technology platform allows Co. to engineer microbes and to metabolize renewable, plant-sourced sugars into ingredients. Co. has focused its development activities primarily on the production of Biofene®, its brand of renewable farnesene, a branched hydrocarbon molecule that manufactures through fermentation using engineered microbes. Co.'s farnesene derivatives are sold in various products including nutraceuticals, skin care, fragrances, solvents, and lubricants ingredients. We show 8 historical shares outstanding datapoints in our AMRS shares outstanding history coverage, used to compute AMRS market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AMRS market cap history over the course of time is important for investors
interested in comparing AMRS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AMRS versus a peer is one thing; comparing
AMRS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AMRS can fluctuate over the course of history.
With this page we aim to empower investors researching AMRS by allowing them to research the AMRS market cap history.